Acrospire Investment Management LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$90,000
-25.0%
14,609
-25.7%
0.07%
+51.0%
Q4 2016$120,000
+96.7%
19,653
+135.2%
0.05%
+19.5%
Q3 2016$61,000
-14.1%
8,355
-1.2%
0.04%
-22.6%
Q2 2016$71,0008,4550.05%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders